Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found genes linked to feather growth speed in Shouguang chickens, highlighting two genes that might explain differences in feathering.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Immune cells affect hair growth and could lead to new hair loss treatments.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Patients generally feel positive about alopecia areata treatments, but emotions vary by treatment type.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

CD2 might be a new treatment target for patchy alopecia areata.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Understanding hair growth involves complex factors, and more research is needed to improve treatments for hair loss conditions.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Oral tofacitinib successfully treated total body hair loss in one patient.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

Genomic research can help improve the quality and production of natural fibers in animals.